Management of Elevated TSH in Levothyroxine‑Treated Patients
Assessment Before Dose Adjustment
- Evaluate medication adherence and potential absorption problems (e.g., gastrointestinal disease, interacting drugs, timing of ingestion) before modifying levothyroxine dose. 1, 2
Dose‑Adjustment Recommendations
- A TSH of 12.8 mIU/L in a patient already receiving levothyroxine signifies subclinical hypothyroidism that requires dose titration. 1, 2
- Guidelines advise that all treated hypothyroid patients should have TSH restored to the laboratory’s reference range. 1, 2
- When TSH remains in the upper half of the normal range and the patient is still symptomatic, further dose increase to achieve a lower‑normal TSH is reasonable. 1, 2
Monitoring After Dose Change
- Re‑measure TSH 6–8 weeks after any levothyroxine dose adjustment to ensure steady‑state levels before making additional changes. (Evidence cited in the same sources that support dose adjustment.) 1, 2
Special Populations
Pregnancy or Planned Pregnancy
- Increase levothyroxine dose promptly and monitor TSH every 4 weeks during pregnancy. 2, 3, 4
- Levothyroxine requirements rise by approximately 25–50 % in pregnant patients. 2, 4
- Elevated maternal TSH during pregnancy is linked to higher rates of fetal loss and neurodevelopmental deficits in offspring. 2, 3, 4